explorer, geographer, mathematician and scientist,' left England in the Endeavour in 1768 to observe the passage of Venus across the face of the sun. This expedition led on to his meticulous explorations of the South Pacific and Australia in 1770 and the making of a major contribution to the 'complete solution of geography'.
By 1770 the science of geography was well established but the science of immunology was unknown. Its founder, Edward Jenner, was a contemporary of James Cook and was employed by Joseph Banks to prepare the biological specimens procured from the South Pacific. LeFanu (1951) wrote that Jenner's skill, dexterity and judgment so pleased Banks that Jenner was offered the post of naturalist for Cook's second voyage in 1772. Jenner declined for he preferred to practise as a country doctor in his native Gloucestershire-this was a fortunate decision for it led to Jenner's discovery that cowpox infection protected against smallpox infection and the introduction of prophylactic vaccination. Thus born, the infant science of immunology at first grew slowly, for nearly 100 years were to pass before the further discoveries by Pasteur on prophylactic immunization, cellular immunology by Metchnikoff, delayed hypersensi-tivity by Koch, the description of a selective theory of antibody production by Ehrlich, and discoveries leading to serodiagnosis by Bordet, Widal and Wassermann. So microbiology and immunology became linked as one science, and remain so even today in many traditionalist universities. But these sciences have now diverged, and many of the 'growing points' of immunology-transplantation, cancer immunology and autoimmunity-have little connection with microbiology. So, for immunology to progress to its 'complete solution' we must encourage the development of new, strong and independent Departments and Institutes of Immunology in Universities tJiroughout the world. This paper is a subjective appraisal of ten of the growing points of immunology-several of these are interrelated, as illustrated in Fig. 1 , and three cover the more clinically oriented fields of cancer, trans-< plantation and autoimmunity. mmunological differentiation Immunological differentiation is a broad growing point which overlaps into many other sciences including embryology, morphogenesis and oncology: it is concerned with processes by which cells obtain the information which directs them towards specialized function.
For the immunological and haemopoietic system, the ancestral undifferentiated cell appears to originate in blood islands of the yolk sac. In the chick embryo stem cells were shown to enter the thymus and bursa of Fabricius, and this determined the subsequent lymphopoietic activity in these tissues (Moore & Owen, 1967) . Moore & Metcalf (1970) showed that the system initially worked out in the chicken held also for the mouse and presumably all mammals: pluri-potential stem cells in the yolk sac of the embryo migrate to the liver, the site of foetal haemopoiesis, and later to the bone marrow, the site of adult haemopoiesis. (Metcalf & Stanley, 1969 Hayflick (1968) showed that cultured human embryonic fibroblasts doubled about fifty times and then ceased dividing, and fibroblasts from adults underwent even fewer doublings in culture, 14-29, suggesting that they had already 'used (Gowans & McGregor, 1965; Ford & Gowans, 1969 (Warner & Szenberg, 1964) (Fig. 2) (Mandel, Byrt & Ada, 1969 (Warner, Byrt & Ada, 1970) , whereas for lymphocytes involved in cellular immunity (T-lymphocytes) it may be a new immunoglobulin class (Mason & Warner, 1970) . Attachment of antigen to these receptors acts as a proliferative and mitogenic stimulus and this may be the initiating event in the immune response. Conversely inactivation of these receptors may 'tolerize' the cell.
The generic name of 'lymphokine' has been given to a number of soluble factors produced by activated lymphocytes (Dumonde et al., 1969) , including mitogenic factor, macrophage inhibitory factor, cytopathic factor, inflammatory factor and transfer factor. Lymphokines, once produced, are active in the absence of the cells which produced them. The mitogenic factor stimulates DNA metabolism and division of lymphocytes, the cytopathic factor damages monolayers of target cells, the macrophage inhibitory factor (MIF) inhibits the migration of macrophages in vitro, and the 'transfer factor' confers specific reactivity on non-sensitized lymphocytes (Valentine & Lawrence, 1969 (Sercarz & Byers, 1967) and the antigen-reactive cell in modem parlance (Miller & Mitchell, 1969 (Dwyer & Mackay, 1970) . Blood lymphocytes are mixed with radioiodine-labelled flagellin and cell smears are examined by radioautography-a proportion of cells have labelled antigen specifically bound to their surface (Fig. 3) . These 'antigen-binding lymphocytes' were demonstrated in the human foetal spleen (1/2000 lymphocytes) and blood of non-immunized adults in whom there is 'natural' antibody to flagellin (3-5/1000 lymphocytes); their number in the blood increased eight-fold 7-10 days after immunization with flagellin.
Cell collaboration in immune responses
The concept of cell collaboration in immune responses was introduced 10 years ago in relation to macrophage-lymphocyte interaction (Fishman, 1961 (Claman & Chaperon, 1969; Miller, 1969 (Feldmann & Diener, 1970) .
Immunoglobulins and immunogenetics
The understanding of the molecular structure and heterogeneity of immunoglobulins (Edelman & Gall, 1969; Warner, 1969) (Walford, 1969) . Ting & Morris (1970) suggested that the genetic control of the HL-A system may be analogous to that of other cell surface antigens, e.g. ABH antigens, and that 4a and 4b may be precursor substances controlled at a separate locus to the loci controlling the other leucocyte antigens, the specificities of which are derived from gene action on these precursor substances. Biochemical purification of histocompatibility antigens will be needed to resolve this. Despite the complexity of the HL-A system, matching of donors and recipients in renal transplantation significantly influences the survival of an organ graft.
Recognition of foreignness occurs when patrolling long-lived lymphocytes encounter differing histocompatibility antigens on cells of the graft. Lymphocytes capable of recognizing histocompatibility antigens are disproportionately well represented in the small lymphocyte population (Jerne, 1970), suggesting that the capacity during evolution to recognize histocompatibility antigens must have conferred strong survival advantages. Burnet Rejection is effected mainly by sensitized cytotoxic lymphocytes which invade and destroy the graft (Hall, 1969; Najarian & Foker, 1969 (Thomson et al., 1970 (Lewis et al., 1969 (Mackay, 1968 (Mackay, , 1969 (Rowley, Mackay & McKenzie, 1969 
